Tomer Cohen

Tomer Cohen

Company: KAHR Medical

Job title: Chief Business Officer

Seminars:

Learning from DSP107, a CD47x4-1BB bi-specific, to Advance Therapies into the Future & Consider the Continued Therapeutic Potential of CD47 11:30 am

Improving target specificity and activity using bi-specific fusion protein Transforming safety profile and avoiding hematological toxicities Enhancing the treatment potential of solid and hematological malignanciesRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.